U.S. Industrials Stock News

LegalZoom.com (LZ) is back on investors’ radar after a Barclays downgrade raised questions about its market size and AI competition, just as the company rolled out deeper attorney-services integration with the Claude AI ecosystem. See our latest analysis for LegalZoom.com. At a share price of US$6.67, LegalZoom.com’s 30-day share price return of 17.14% and year-to-date share price return decline of 30.45%, alongside a 12-month total shareholder return decline of 27.97% and 3-year total...

Las Vegas Sands recently completed a major leadership shift, appointing Patrick Dumont as chairman, chief executive officer, president, and treasurer and locking in new five‑year contracts for him and other senior executives with sizable pay, incentives, and protections. These long-dated agreements, with features such as US$2,500,000 annual base pay for Dumont and extensive equity incentives, highlight the board’s emphasis on continuity and alignment between top management and...

Reinsurance Group of America (NYSE:RGA) has appointed Jayson Bronchetti as Executive Vice President, Investments. Bronchetti will succeed Leslie Barbi, who is retiring from the role. The appointment places Bronchetti in charge of the insurer's investment management function. Reinsurance Group of America, trading at $207.17, has experienced varying share price movements across different timeframes, with a 7 day return of a 4.5% decline and a 30 day return of an 8.1% decline, alongside a 1...

First Solar is facing rising concern over a rapidly shrinking order backlog, with net bookings reportedly turning negative. The company’s backlog is being depleted faster than new contracts are signed, raising the risk of an order cliff around 2028. Investors are also focused on First Solar’s heavy reliance on Section 45X tax credits, which are scheduled to phase out between 2030 and 2033. First Solar, NasdaqGS:FSLR, is coming under closer scrutiny as its order book thins while its share...

In March 2026, Victory Capital Holdings, Inc. appointed Molly Weiss as Chief Technology Officer and Head of Digital Innovation, giving her executive responsibility for the firm’s technology infrastructure, artificial intelligence framework, data and analytics platform, and Direct Investor Business. By placing a seasoned wealth-technology leader with product, distribution, and user-experience expertise at the center of its technology and direct-investor efforts, Victory Capital appears to be...

In recent days, Booking Holdings reported stronger-than-expected Q4 2025 results, approved a 25-for-1 forward stock split effective April 2, 2026, raised its quarterly dividend for payment on March 31, 2026, and outlined 2026 guidance that targets constant-currency growth above its prior framework alongside EBITDA margin expansion and mid-teens adjusted EPS growth. At the same time, market concerns about AI upending online travel agencies eased after OpenAI scaled back plans for in-chat...

Recent analyst upgrades and a 35.3% upward move in consensus full year earnings estimates have pushed Bank First (BFC) into focus, as its Zacks Rank now highlights stronger sentiment around the stock. See our latest analysis for Bank First. Despite the recent analyst upgrades and earnings revisions, Bank First’s share price has cooled in the short term, with a 10.0% 1-month share price return decline. However, the 13.0% year-to-date share price return and 43.2% 1-year total shareholder return...

Why Axalta Coating Systems (AXTA) Is On Investors’ Radar Axalta Coating Systems (AXTA) has caught investor attention after recent share price weakness, with the stock showing a 2.1% decline over the past day and a 9.1% pullback over the past week. With the shares now about 12.4% lower over the past month yet slightly positive over the past 3 months, some investors are reassessing how Axalta’s valuation lines up with its fundamentals and recent financial performance. See our latest analysis...

Standex International has completed the sale of its Federal Industries display merchandising business to AeriTek Global Holdings LLC, further simplifying its portfolio and sharpening its focus on core operations. The company plans to channel proceeds from the divestiture into internal growth projects, acquisitions, and debt reduction, potentially reshaping its balance between expansion and financial flexibility. We'll now explore how this divestiture, and Standex's intention to reinvest...

Oruka Therapeutics recently initiated an open-label extension Phase 2 study of its lead candidate ORKA-001 to assess long-term safety, tolerability, and efficacy in patients with moderate-to-severe plaque psoriasis, including evaluation of different dosing schedules such as potentially once-yearly administration. This focus on durability and reduced dosing frequency could position ORKA-001 as a differentiated option in the psoriasis treatment landscape if longer-term data support sustained...

In late February 2026, Arbor Realty Trust reported fourth-quarter 2025 results showing higher sales of US$7.32 million but lower net income of US$24.92 million, alongside a US$20.50 million impairment on real estate owned and a maintained quarterly dividend of US$0.30 per share. The combination of weaker earnings, sizable impairment charges and management’s continued commitment to its dividend policy has sharpened investor focus on Arbor’s approach to resolving distressed real estate and...

In recent days, Newmont has faced pressure as gold prices softened despite geopolitical tensions, while the company projected an almost 10% drop in gold output this year and insiders continued selling shares under prearranged plans. At the same time, analysts highlighted Newmont’s strong balance sheet, substantial mineral reserves, and mixed views on production growth versus rising costs. Newmont’s recent results included record free cash flow and net income in 2025 and a balance sheet with...

In early March 2026, Simon Property Group, Inc. announced that its operating partnership amended, restated, and extended a US$5.00 billion multi-currency unsecured revolving credit facility to mature in 2030, while also aligning pricing on its US$3.50 billion supplemental facility, lowering borrowing costs and enhancing liquidity. This refreshed credit framework gives Simon more financial flexibility to fund redevelopment, densification, and potential acquisitions that could reshape its...

In late February and early March 2026, Verisk Analytics held its Investor Day and completed US$1.00 billion of new senior note offerings, largely to refinance short-term borrowings tied to accelerated share repurchases and for general corporate purposes. Management used Investor Day to reiterate medium-term growth and profitability targets while committing to return at least 75% of free cash flow to shareholders through dividends and buybacks, highlighting a clear capital allocation...

Rocket Lab (NasdaqCM:RKLB) completes two satellite launches from different countries within a single week. The company showcases space qualified silicon solar arrays designed for gigawatt scale power in orbital data centers. New solar technology targets radiation hardened, cost focused power systems for next generation space based AI and data infrastructure. Rocket Lab sits at the intersection of launch services, spacecraft components, and in space infrastructure, and this latest news...

KeyCorp recently announced that Chief Information Officer Amy G. Brady resigned effective March 2, 2026 for personal health reasons, while continuing in a non-executive transition role through May 31, 2026 to ensure an orderly handover of her responsibilities. At the same time, KeyBank’s recognition of its East Ohio market and its investment in a new full-service branch in Black Diamond, Washington highlight ongoing efforts to deepen community banking relationships even as investors focus on...

Annual earnings and new shelf registration reshape Relay Therapeutics story Relay Therapeutics (RLAY) has just reported its full year 2025 results, pairing higher reported revenue and a smaller net loss with a new US$96.2 million shelf registration for potential common stock issuance. See our latest analysis for Relay Therapeutics. The earnings update, new US$96.2 million shelf registration and recent conference appearance come as Relay Therapeutics’ share price trades at US$9.89, with a 90...

Why Apogee Therapeutics is in focus after earnings and a new shelf registration Apogee Therapeutics (APGE) has come into focus after reporting a full year 2025 net loss of US$255.84 million, along with a new US$287.29 million shelf registration for additional common stock. See our latest analysis for Apogee Therapeutics. At a share price of US$73.05, Apogee Therapeutics has delivered a 30 day share price return of 17.37% and a 1 year total shareholder return of 94.59%. This suggests that...

In early March 2026, Radware launched a cloud-based Web DDoS Protection service for encrypted traffic that blocks sophisticated layer 7 attacks without requiring SSL certificate sharing or traffic decryption, addressing privacy, regulatory, and key management concerns. The company claims to be the only provider offering this kind of cloud-based encrypted DDoS protection, combining AI-driven behavioral analysis with flexible cloud, on-premises, hybrid, and Kubernetes-native deployment...

Mason Capital Management recently disclosed in an SEC filing that it purchased more than 1.1 million additional shares of Brookdale Senior Living, materially increasing its ownership position and signaling stronger institutional interest in the senior living operator. This larger stake, built as Brookdale continues to emphasize operational efficiency and demographic demand tailwinds, raises fresh questions about how institutional involvement could shape the company’s longer-term direction...

Investor worries around hidden risks in the private credit market have weighed on regional banks, and Byline Bancorp (BY) has been pulled into that broader sector pressure as sentiment has cooled. See our latest analysis for Byline Bancorp. The share price has softened recently, with a 1-day share price return of 1.72% and a 30-day share price return of 8.03%, even though the 1-year total shareholder return of 19.24% and 3-year total shareholder return of 63.58% point to momentum that has...

In late February 2026, Privia Health Group reported fourth-quarter 2025 revenue of US$541.17 million and net income of US$9.15 million, alongside full-year 2025 revenue of US$2.12 billion and net income of US$22.92 million, while separately publishing a case study on a nationwide colorectal cancer screening program that reached over 100,000 patients. The colorectal cancer initiative, integrating Amalgam Rx’s clinical workflows and Exact Sciences’ Cologuard test into Privia’s EHR, lifted...

Morningstar’s new AI assistant and what it could mean for the stock Morningstar (MORN) has rolled out a new AI assistant in beta to part of its 4,000 advisor base, integrating research, portfolio analysis, and proposal tools through natural language prompts within its Direct Advisory Suite. See our latest analysis for Morningstar. The new AI assistant arrives alongside other recent initiatives, such as Morningstar’s collaboration with the University of Illinois and fresh PitchBook research on...

Why Chesapeake Utilities is on investors’ radar Chesapeake Utilities (CPK) has been drawing attention after recent share price moves, with the stock roughly flat over the past day but slightly weaker over the past week and higher over the past 3 months. See our latest analysis for Chesapeake Utilities. Looking beyond the latest move, Chesapeake Utilities’ 30 day share price return of 1.83% and 90 day share price return of 5.19% sit alongside a 1 year total shareholder return of 4.86%,...